J. Trasler, B. Hales, and B. Robaire, Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility, Nature, vol.54, issue.6024, pp.144-150, 1985.
DOI : 10.1038/316144a0

J. Trasler, B. Hales, and B. Robaire, Chronic Low Dose Cyclophosphamide Treatment of Adult Male Rats: Effect on Fertility, Pregnancy Outcome and Progeny1, Biology of Reproduction, vol.34, issue.2, pp.275-83, 1986.
DOI : 10.1095/biolreprod34.2.275

E. Schirm, L. Pedersen, H. Tobi, G. Nielsen, H. Sørensen et al., Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands, Pharmacoepidemiology and Drug Safety, vol.13, issue.9, pp.609-622, 2004.
DOI : 10.1002/pds.959

A. Engeland, J. Bramness, A. Daltveit, M. Rønning, S. Skurtveit et al., Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106??000 pregnancies in Norway 2004???2006, British Journal of Clinical Pharmacology, vol.14, issue.5, pp.653-60, 2004.
DOI : 10.1002/pds.1225

A. Engeland, T. Bjørge, A. Daltveit, S. Skurtveit, S. Vangen et al., Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340???000 pregnancies using Norwegian population-based databases, British Journal of Clinical Pharmacology, vol.10, issue.4, pp.1134-1175, 2012.
DOI : 10.1111/j.1365-2125.2012.04426.x

I. Crijns, J. Bos, M. Knol, S. Straus, and L. De-jong-van-den-berg, Paternal drug use: before and during pregnancy, Expert Opinion on Drug Safety, vol.90, issue.4, pp.513-521, 2012.
DOI : 10.1016/0890-6238(92)90190-5

M. Hoeltzenbein and C. , Paternal exposure to drugs???Is there an increased risk for congenital abnormalities?: Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment during Pregnancy, Reproductive Toxicology, vol.26, issue.1, pp.64-64, 2008.
DOI : 10.1016/j.reprotox.2008.05.023

D. Santis, M. Cesari, E. Cavaliere, A. Ligato, M. Nobili et al., Paternal exposure and counselling: Experience of a Teratology Information Service, Reproductive Toxicology, vol.26, issue.1, pp.42-48, 2008.
DOI : 10.1016/j.reprotox.2008.06.003

C. Lee, J. C. Mata, A. Tanaka, T. Einarson, A. Koren et al., A pilot study of paternal drug exposure: The Motherisk experience, Reproductive Toxicology, vol.29, issue.3, pp.353-60, 2010.
DOI : 10.1016/j.reprotox.2010.01.008

B. Hales, S. Smith, and B. Robaire, Cyclophosphamide in the seminal fluid of treated males: Transmission to females by mating and effect on pregnancy outcome, Toxicology and Applied Pharmacology, vol.84, issue.3, pp.423-453, 1986.
DOI : 10.1016/0041-008X(86)90247-4

S. Pichini, P. Zuccaro, R. Pacifici, and A. Scialli, The transport of chemicals in semen, Drugs in Semen. Clin Pharmacokinet. 1 mai Birth Defects Res B Dev Reprod Toxicol. avr, vol.2674, issue.52, pp.119-150, 1994.

A. Wyrobek, L. Gordon, J. Burkhart, M. Francis, R. Kapp et al., An evaluation of human sperm as indicators of chemically induced alterations of spermatogenic function, Mutation Research/Reviews in Genetic Toxicology, vol.115, issue.1, pp.73-148, 1983.
DOI : 10.1016/0165-1110(83)90015-5

J. Trasler and T. Doerksen, Teratogen update: paternal exposures?reproductive risks, Teratology, vol.115, issue.8051, pp.161-72, 1999.
DOI : 10.1002/(SICI)1096-9926(199909)60:3<161::AID-TERA12>3.0.CO;2-A

R. Martin, A. Rademaker, and N. Leonard, Analysis of chromosomal abnormalities in human sperm after chemotherapy by karyotyping and fluorescence in situ hybridization (FISH), Cancer Genetics and Cytogenetics, vol.80, issue.1
DOI : 10.1016/0165-4608(94)00162-5

A. Genescà, J. Benet, M. Caballín, R. Miró, J. Germà et al., Significance of structural chromosome aberrations in human sperm: analysis of induced aberrations, 29?32. 18, pp.495-504, 1990.
DOI : 10.1007/BF00194223

K. Witt and J. Bishop, Mutagenicity of anticancer drugs in mammalian germ cells, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.355, issue.1-2, pp.209-243, 1996.
DOI : 10.1016/0027-5107(96)00029-2

W. Robbins, M. Meistrich, D. Moore, F. Hagemeister, H. Weier et al., Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm, Nature Genetics, vol.6, issue.1, pp.74-82, 1997.
DOI : 10.1007/s004390050268

A. Khallouk, M. Tazi, M. El-fassi, and M. Farib, L'infertilité masculine : physiopathologie, bilan et prise en charge.pdf. Espérance Médicale, juill, vol.17, issue.170, pp.421-430, 2010.

J. Byrne, S. Rasmussen, S. Steinhorn, R. Connelly, M. Myers et al., Genetic Disease in Offspring of Long-Term Survivors of Childhood and Adolescent Cancer, The American Journal of Human Genetics, vol.62, issue.1, pp.45-52, 1998.
DOI : 10.1086/301677

J. Byrne, J. Whitton, M. Stovall, A. Mertens, S. Donaldson et al., Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring Pregnancy Outcome of Partners of Male Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study, Teratology. 1 avr J Clin Oncol. 15 févr, vol.5921, issue.44, pp.716-737, 1999.

J. Winther, B. Jr, . Jd, J. Mulvihill, M. Stovall et al., Chromosomal Abnormalities among Offspring of Childhood-Cancer Survivors in Denmark: A Population- Based Study Disponible sur: http://www.lecrat.org/article.php3? CYtogenetic evaluation of methotrexatetreated psoriatic patients, 1282?5. 26. Etat des connaissances sur les grossesses après cancer [Internet]. [cité 31 août 2014], pp.269-74, 1969.

M. Jensen and A. Nyfors, Cytogenetic effect of methotrexate on human cells in vivo, Mutation Research/Environmental Mutagenesis and Related Subjects, vol.64, issue.5, pp.339-382, 1979.
DOI : 10.1016/0165-1161(79)90126-2

C. Mondello, R. Giorgi, and F. Nuzzo, Chromosomal effects of methotrexate on cultured human lymphocytes, Mutation Research Letters, vol.139, issue.2, pp.67-70, 1984.
DOI : 10.1016/0165-7992(84)90105-2

S. Padmanabhan, D. Tripathi, A. Vikram, P. Ramarao, and G. Jena, Cytotoxic and genotoxic effects of methotrexate in germ cells of male Swiss mice, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.655, issue.1-2, pp.59-67, 2008.
DOI : 10.1016/j.mrgentox.2008.07.003

D. Beghin, M. Cournot, C. Vauzelle, and E. Elefant, Paternal Exposure to Methotrexate and Pregnancy Outcomes, The Journal of Rheumatology, vol.38, issue.4, pp.628-660, 2011.
DOI : 10.3899/jrheum.100600

K. Viktil, A. Engeland, and K. Furu, Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers):196?201. 37. Gromnica-Ihle E, Krüger K. Use of methotrexate in young patients with respect to the reproductive system, Scand J Rheumatol. mai Clin Exp Rheumatol. oct, vol.4128, issue.35, pp.80-84, 2010.

C. Hyoun and . Obi?an, Teratogen update: Methotrexate, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.73, issue.5 Suppl, pp.187-207, 2012.
DOI : 10.1002/bdra.23003

O. Voronova, O. Rogozina, A. Martyushev, S. Sergeeva, O. Epstein et al., Cytogenetic effects of antibodies to gamma-interferon in ultralow doses, Bull Exp Biol Med. janv, vol.135, pp.65-71, 2003.

J. Kim, Y. Lee, W. Koh, C. Kim, I. Choi et al., Genotoxicity Assessment of HM10620 Containing Recombinant Human Interferon-??, Drug and Chemical Toxicology, vol.69, issue.1, pp.83-95, 2007.
DOI : 10.1016/0165-7992(82)90043-4

J. Meng, Z. Yan, Y. Wu, M. Gao, W. Li et al., Preclinical safety evaluation of IFN??2a-NGR, Regulatory Toxicology and Pharmacology, vol.50, issue.3, pp.294-302, 2008.
DOI : 10.1016/j.yrtph.2007.10.014

J. Bussiere, L. Hardy, A. Hoberman, J. Foss, and M. Christian, Reproductive effects of chronic administration of murine interferon-gamma, Reproductive Toxicology, vol.10, issue.5, pp.379-91, 1996.
DOI : 10.1016/0890-6238(96)00084-6

S. Pecou, N. Moinard, M. Walschaerts, C. Pasquier, M. Daudin et al., Ribavirin and pegylated interferon treatment for hepatitis C was associated not only with semen alterations but also with sperm deoxyribonucleic acid fragmentation in humans, Fertility and Sterility, vol.91, issue.3, pp.933-950, 2009.
DOI : 10.1016/j.fertnstert.2008.07.1755

K. Hellwig, A. Haghikia, and R. Gold, Parenthood and immunomodulation in patients with multiple sclerosis, Journal of Neurology, vol.354, issue.4, pp.580-583, 2010.
DOI : 10.1007/s00415-009-5376-z

E. Lu, F. Zhu, Y. Zhao, M. Van-der-kop, A. Synnes et al., Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs, CNS Drugs, vol.229, issue.2, pp.475-82, 2014.
DOI : 10.1007/s40263-014-0154-6

C. Pecori, M. Giannini, E. Portaccio, A. Ghezzi, B. Hakiki et al., Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study, BMC Neurology, vol.139, issue.5, p.114, 2014.
DOI : 10.1016/0165-7992(84)90125-8

K. Hegenbarth, U. Maurer, P. Kroisel, P. Fickert, M. Trauner et al., No evidence for mutagenic effects of ribavirin: report of two normal pregnancies, The American Journal of Gastroenterology, vol.19, issue.1, pp.2286-2293, 2001.
DOI : 10.1016/S0168-8278(99)80154-8

S. Bianca and G. Ettore, Male periconceptional ribavirin-interferon alpha-2B exposure with no adverse fetal effects, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.51, issue.1, pp.77-85, 2003.
DOI : 10.1002/bdra.10105

D. Santis, M. Carducci, B. Cavaliere, A. , D. Santis et al., Case report Paternal exposure to ribavirin: pregnancy and neonatal outcome, Antivir Ther, vol.8, pp.73-78, 2003.

N. Taguchi and S. Ito, Paternal use of ribavirin-interferon alpha 2B combination therapy before conception. Can Fam Physician, 1623?5. 51. Treton X, Bouhnik Y. Place des thiopurines dans le traitement des maladies inflammatoires chroniques intestinales (MICI). Hépato-Gastro Oncol Dig. 1 nov, pp.533-542, 2005.

R. Rajapakse, B. Korelitz, J. Zlatanic, P. Baiocco, and G. Gleim, Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease, The American Journal of Gastroenterology, vol.92, issue.3, pp.684-692, 2000.
DOI : 10.1016/S0140-6736(96)90402-X

B. Nørgård, L. Pedersen, J. Jacobsen, S. Rasmussen, H. Sørensen et al., The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception The safety of 6- mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study, Aliment Pharmacol Ther. 1 mars Gastroenterology. janv, vol.19124, issue.61, pp.9-17, 2003.

C. Teruel, A. López-san-román, F. Bermejo, C. Taxonera, J. Pérez-calle et al., Outcomes of Pregnancies Fathered by Inflammatory Bowel Disease Patients Exposed to Thiopurines, The American Journal of Gastroenterology, vol.53, issue.9, 2010.
DOI : 10.1016/j.earlhumdev.2006.09.015

M. Hoeltzenbein, C. Weber-schoendorfer, C. Borisch, A. Allignol, R. Meister et al., Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine, Reproductive Toxicology, vol.34, issue.3, pp.364-373, 2012.
DOI : 10.1016/j.reprotox.2012.05.001

A. , L. B. Médicaments, and . France, Issue 10) [Internet]. Office of Research and Development, NCKU, Research Express@NCKU -Articles Digest, vol.44, 1998.

G. Briggs, R. Freeman, and S. Yaffe, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 2011.

T. Said, A. Agarwal, T. Falcone, R. Sharma, M. Bedaiwy et al., Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model, Fertility and Sterility, vol.83, issue.6, pp.1665-73, 2005.
DOI : 10.1016/j.fertnstert.2004.11.068

P. Villiger, G. Caliezi, V. Cottin, F. Förger, A. Senn et al., Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis, Annals of the Rheumatic Diseases, vol.69, issue.10, pp.1842-1846, 2010.
DOI : 10.1136/ard.2009.127423

R. Ramonda, C. Foresta, A. Ortolan, A. Bertoldo, F. Oliviero et al., Influence of tumor necrosis factor ?? inhibitors on testicular function and semen in spondyloarthritis patients, Fertility and Sterility, vol.101, issue.2, pp.359-65, 2014.
DOI : 10.1016/j.fertnstert.2013.10.048

U. Mahadevan, J. Terdiman, A. J. Jacobsohn, S. Turek, and P. , Infliximab and Semen Quality in Men With Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.11, issue.4, pp.395-404, 2005.
DOI : 10.1097/01.MIB.0000164023.10848.c4

S. Paschou, P. Voulgari, I. Vrabie, I. Saougou, and A. Drosos, Fertility and Reproduction in Male Patients with Ankylosing Spondylitis Treated with Infliximab, The Journal of Rheumatology, vol.36, issue.2, pp.351-355, 2009.
DOI : 10.3899/jrheum.080554

F. Lamboglia, R. Incà, L. Oli-a, and . Bertomoro, Patient with Severe Crohn??s Disease Became a Father While on Methotrexate and Infliximab Therapy, Inflammatory Bowel Diseases, vol.15, issue.5, pp.648-657, 2009.
DOI : 10.1002/ibd.20722

N. Ansari, W. Von-der, and M. , Hémato-oncologie pédiatri ue : de la biologie cellulaire aux traitements ciblés et individualisés. Pédiatrie. 22 févr 2012, pp.403-411

J. Iqbal, Z. Ali, A. Khan, and Z. Aziz, Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country, Leukemia & Lymphoma, vol.55, issue.9, pp.2109-2122, 2014.
DOI : 10.1002/cncr.22498

L. Zhou, J. You, W. Wu, J. Li, Z. Shen et al., Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor, Leukemia Research, vol.37, issue.10, pp.1216-1237, 2013.
DOI : 10.1016/j.leukres.2013.07.020

Q. Jiang, B. Jiang, S. Chen, H. Jiang, Y. Qin et al., Pregnancy outcome among patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors], Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. janv, vol.33, issue.1, pp.6-9, 2012.

K. Ramasamy, J. Hayden, Z. Lim, G. Mufti, and A. Ho, Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy, British Journal of Haematology, vol.137, issue.4, pp.374-379, 2007.
DOI : 10.1056/NEJM200411113512024

. Ault, H. Kantarjian, . O-'brien, . Faderl, M. Beran et al., Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib, Journal of Clinical Oncology, vol.24, issue.7, pp.1204-1212, 2006.
DOI : 10.1200/JCO.2005.04.6557

M. Hensley and J. Ford, Imatinib treatment: Specific issues related to safety, fertility, and pregnancy, Seminars in Hematology, vol.40, pp.21-26, 2003.
DOI : 10.1053/shem.2003.50038

B. Fulton and A. Markham, Mycophenolate Mofetil, Drugs, vol.51, issue.2, pp.278-98, 1996.
DOI : 10.2165/00003495-199651020-00007

C. Legendre and E. Thervet, La pharmacologie des immunosuppresseurs actuels. Médecine Thérapeutique. 3 mars 1999, pp.101-108

V. Oliveira, H. Zankl, and T. Rath, Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures, Exp Clin Transplant Off J Middle East Soc Organ Transplant. déc, vol.2, issue.2, pp.273-282, 2004.

M. Hoeltzenbein, E. Elefant, T. Vial, V. Finkel-pekarsky, S. Stephens et al., Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services, American Journal of Medical Genetics Part A, vol.214, issue.3, pp.588-96, 2012.
DOI : 10.1002/ajmg.a.35223

P. Merlob, B. Stahl, and G. Klinger, Tetrada of the possible mycophenolate mofetil embryopathy: A review???, Reproductive Toxicology, vol.28, issue.1, pp.105-113, 2009.
DOI : 10.1016/j.reprotox.2009.02.007

A. Jones, M. Clary, E. Mcdermott, L. Coscia, S. Constantinescu et al., Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products, Progress in Transplantation, vol.60, issue.2, pp.153-160, 2013.
DOI : 10.7182/pit2013636

H. Jeulin, F. Kedzierewicz, N. Grancher, and V. Venard, Quel avenir pour la ribavirine en dehors de l'hépatite C ? Virologie. 1 mars, pp.83-92, 2009132.

. Résumé-des-caractéristiques-du-produit, Evaluation of the role of the antioxidant silymarin in modulating the in vivo genotoxicity of the antiviral drug ribavirin in mice, Disponible sur, pp.14-20, 2013.

K. Narayana, U. Eetharama-rao, and K. , The genotoxic and cytotoxic effects of ribavirin in rat bone marrow, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.521, issue.1-2, pp.179-85, 2002.
DOI : 10.1016/S1383-5718(02)00239-5

M. Wc, Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis Crelapsed and treatment-naive patients, Semin Liver Dis. déc, vol.19, issue.1, pp.67-75, 1998.

S. Roberts, R. Miller, J. Jones, K. Lindsay, M. Greene et al., The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.62, issue.Suppl 1, pp.551-560, 2003.
DOI : 10.1002/bdra.20682

V. Ferm, C. Willhite, and L. Kilham, Teratogenic effects of ribavirin on hamster and rat embryos, Teratology, vol.15, issue.1, pp.93-101, 1978.
DOI : 10.1002/tera.1420170117

H. Hofer, J. Donnerer, K. Sator, K. Staufer, T. Scherzer et al., Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy, Journal of Hepatology, vol.52, issue.6, pp.812-818, 2010.
DOI : 10.1016/j.jhep.2009.12.039

V. Hoting, B. Schütte, and C. Schirren, Isotretinoin treatment of acne conglobata Andrologic follow-up], Fortschr Med. 20 août, vol.110, issue.23, 1992.

W. Dai, J. Labraico, and R. Stern, Epidemiology of isotretinoin exposure during pregnancy, Journal of the American Academy of Dermatology, vol.26, issue.4, pp.599-606, 1992.
DOI : 10.1016/0190-9622(92)70088-W

F. Bernard, C. Barrault, A. Deguercy, D. Wever, B. Rosdy et al., Expression of type 1 5??-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic??): a new model for screening skin-targeted androgen modulators, International Journal of Cosmetic Science, vol.10, issue.6, pp.397-407, 2000.
DOI : 10.1111/j.1468-2494.2000.00035.x

H. Tu and A. Zini, Finasteride-induced secondary infertility associated with sperm DNA damage PRODUCT Disponible sur: http://secure.healthlinks.net.au/content/msd/pi.cfm?product=mkpprope 97, PMD. Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat, pp.2125-2138, 2003.

S. Prahalada, A. Tarantal, G. Harris, K. Ellsworth, A. Clarke et al., Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta), Teratology, vol.5, issue.2, pp.119-150, 1997.
DOI : 10.1002/(SICI)1096-9926(199702)55:2<119::AID-TERA1>3.0.CO;2-Z

E. Laborde and R. Brannigan, Effect of 1-mg Dose of Finasteride on Spermatogenesis and Pregnancy, Journal of Andrology, vol.31, issue.2, pp.1-2, 2010.
DOI : 10.2164/jandrol.109.009381

A. Wood, R. Rittmaster, and . Finasteride, Finasteride, New England Journal of Medicine, vol.330, issue.2, pp.120-125, 1994.
DOI : 10.1056/NEJM199401133300208

A. Detail and -. , Disponible sur: unmht, 2014.

M. Tallent, R. Simmons, and J. Najarian, Birth Defects in Child of Male Recipient of Kidney Transplant, JAMA: The Journal of the American Medical Association, vol.211, issue.11, pp.1854-1859, 1970.
DOI : 10.1001/jama.1970.03170110060018

L. Wagoner, D. Taylor, G. Price, M. Hagan, C. Holland et al., PATERNITY BY CARDIAC TRANSPLANT RECIPIENTS, Transplantation, vol.57, issue.9, pp.1337-1377, 1994.
DOI : 10.1097/00007890-199405150-00009

. Le-bilan-d, une fausse couche spontanée précoce [Internet]. [cité 17, Disponible sur, 2014.

B. Blondel and G. Bréart, Mortinatalit?? et mortalit?? n??onatale, EMC - P??diatrie, vol.1, issue.1, pp.97-108, 2004.
DOI : 10.1016/j.emcped.2003.09.002

C. Cotzias, S. Paterson-brown, and N. Fisk, Prospective risk of unexplained stillbirth in singleton pregnancies at term: population based analysis, BMJ, vol.319, issue.7205, pp.287-295, 1999.
DOI : 10.1136/bmj.319.7205.287

I. Lacroix, C. Hurault, M. Sarramon, C. Guitard, A. Berrebi et al., Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database, European Journal of Clinical Pharmacology, vol.45, issue.1, pp.839-885, 2009.
DOI : 10.1007/s00228-009-0647-2

URL : https://hal.archives-ouvertes.fr/hal-00534955

E. Carlsen, A. Giwercman, N. Keiding, and N. Skakkebaek, Evidence for decreasing quality of semen during past 50 years., BMJ, vol.305, issue.6854, pp.609-622, 1992.
DOI : 10.1136/bmj.305.6854.609

S. Swan, E. Elkin, and L. Fenster, The Question of Declining Sperm Density Revisited: An Analysis of 101 Studies Published 1934-1996, Environmental Health Perspectives, vol.108, issue.10, pp.961-967, 2000.
DOI : 10.1289/ehp.00108961

B. Blondel and M. Kermarrec, Enquête nationale périnatale, Paris Inst Natl Santé Rech Médicale [Internet] Disponible sur, 2011.

C. Damase-michel, I. Lacroix, C. Hurault-delarue, A. Beau, J. Montastruc et al., ??valuation des m??dicaments chez la femme enceinte : ?? propos de la base de donn??es fran??aise EFEMERIS, Th??rapie, vol.69, issue.1, pp.91-100, 2014.
DOI : 10.2515/therapie/2014005